Molecular mechanisms of dominant negative activity by nuclear hormone receptors.

作者: P M Yen , W W Chin

DOI: 10.1210/MEND.8.11.7877614

关键词:

摘要: Human hereditary syndromes have been divided into three major classes according to Mendelian inheritance patterns-autosomal dominant, autosomal recessive, and X-linked recessive. However, recent advances in molecular biology shed deeper insight the nature of some these as specific gene mutations functional consequences described. Often, are transmitted via germ line. development certain tumors, somatic mutation or a coupled with an inherited defective allele (i.e. tumor suppressor genes such retinoblastoma ~53) is required. Such genetic can be categorized respect their function-gain function (resulting either increased normal acquisition novel function), loss function, dominant negative activity. The latter term refers ability product mutant interfere directly wild type protein (1). Examples each types exist within nuclear hormone receptor superfamily, class ligand-regulatable transcription factors that includes steroid hormone, vitamin D, retinoic acid, thyroid receptors (TRs). These all contain central DNA-binding domain two zinc finger motifs carboxyterminal ligand binding (LBD) which important for well homoand/or heterodimerization other proteins. Several examples gain occurred due chromosomal rearrangements encoding acid (RAR) isoforms, resulting fusion In acute promyelocytic leukemia, PML-RAR proteins formed between myeloid unknown PML, RARcY disrupt subnuclear organization nucleus, perhaps by redirecting retinoid X

参考文章(18)
P.M. Yen, M. Ikeda, J.H. Brubaker, M. Forgione, A. Sugawara, W.W. Chin, Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA. Journal of Biological Chemistry. ,vol. 269, pp. 903- 909 ,(1994) , 10.1016/S0021-9258(17)42197-1
ME Huang, YC Ye, SR Chen, JR Chai, JX Lu, L Zhoa, LJ Gu, ZY Wang, Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia Blood. ,vol. 72, pp. 567- 572 ,(1988) , 10.1182/BLOOD.V72.2.567.567
D P McDonnell, M E Goldman, RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. Journal of Biological Chemistry. ,vol. 269, pp. 11945- 11949 ,(1994) , 10.1016/S0021-9258(17)32664-9
Jan Sap, Alberto Muñoz, Jackie Schmitt, Henk Stunnenberg, Björn Vennström, Repression of transcription mediated at a thyroid hormone response element by the v- erb-A oncogene product Nature. ,vol. 340, pp. 242- 244 ,(1989) , 10.1038/340242A0
Marc-Etienne Meyer, Hinrich Gronemeyer, Bernard Turcotte, Marie-Thérèse Bocquel, Diane Tasset, Pierre Chambon, Steroid hormone receptors compete for factors that mediate their enhancer function Cell. ,vol. 57, pp. 433- 442 ,(1989) , 10.1016/0092-8674(89)90918-5
Gerhart Graupner, Ken N. Wills, Maty Tzukerman, Xiao-kun Zhang, Magnus Pfahl, Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity Nature. ,vol. 340, pp. 653- 656 ,(1989) , 10.1038/340653A0
Akihiro Sakurai, Takahide Miyamoto, Samuel Refetoff, Leslie J. DeGroot, Dominant Negative Transcriptional Regulation by a Mutant Thyroid Hormone Receptor-β in a Family with Generalized Resistance to Thyroid Hormone Molecular Endocrinology. ,vol. 4, pp. 1988- 1994 ,(1990) , 10.1210/MEND-4-12-1988
William L. McGuire, Gary C. Chamness, Suzanne A. W. Fuqua, Estrogen receptor variants in clinical breast cancer. Molecular Endocrinology. ,vol. 5, pp. 1571- 1577 ,(1991) , 10.1210/MEND-5-11-1571